Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression

Medical Decision Making

Volumn 28, Issue 5, 2008, Pages 732-750

  Edelen, Maria Orlando ^a   Burnam, M Audrey ^a   Watkins, Katherine E ^a   Escarce, José J ^a   Huskamp, Haiden ^b   Goldman, Howard H ^c   Rachelefsky, Gary ^d,e  

^a RAND CORPORATION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Allergy Research Foundation   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Consensus panel; Depression; Expert panel; Health value; Treatment benefit

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE;

ARTICLE; ASTHMA; CONSENSUS; COST BENEFIT ANALYSIS; DEPRESSION; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH STATUS; PSYCHOTHERAPY; TREATMENT INDICATION;

ASTHMA; ATTITUDE TO HEALTH; CONSENSUS; DEPRESSION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX;

EID: 52149099472     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X08315251     Document Type: Article

References (39)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academy Press ; 2001.
2. McGlynn EA, Asch SM, Adams J., et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003 ; 348 (26). 2635-45.
3. Gold MR, Siegel JE, Russell LB, Winstein MC Cost-effectiveness in Health and Medicine. New York: Oxford University Press ; 1996.
4. Gafni A., Birch S. Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med. 1995 ; 40 (6). 767-76.
5. Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989 ; 9 (2). 142-9.
6. Mehrez A., Gafni A. Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress. Med Decis Making. 1993 ; 13 (4). 287-92.
7. Badia X., Monserrat S., Roset M., Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999 ; 8 (4). 303-10.
8. Ubel PA, Loewenstein G., Scanlon D., Kamlet M. Individual utilities are inconsistent with rationing choices: a partial explanation of why Oregon's cost-effectiveness list failed. Med Decis Making. 1996 ; 16 (2). 108-16.
9. Ubel PA, Nord E., Gold M., Menzel P., Prades JL, Richardson J. Improving value measurement in cost-effectiveness analysis. Med Care. 2000 ; 38 (9). 892-901.
10. Sherbourne CD, Unutzer J., Schoenbaum M., et al. Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression ? Med Care. 2001 ; 39 (11). 1246-59.
11. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000 ; 38 (6). 583-637.
12. Fryback DG, Lawrence WF, Martin PA, Klein R., Klein BE Predicting quality of well-being scores from the SF-36: results from the Beaver Dam health outcomes study. Med Decis Making. 1997 ; 17 (1). 1-9.
13. Brazier J., Usherwood T., Harper R., Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol. 1998 ; 51 (11). 1115-28.
14. Linstone HA, Turoff M. The Delphi Method: Techniques and Applications. Reading (MA): Addison-Wesley ; 1975.
15. Allen J., Dyas J., Jones M. Building consensus in health care: a guide to using the nominal group technique. Br J Community Nurs. 2004 ; 9 (3). 110-4.
16. Carson C., Giuliano F., Goldstein I., et al. The ''effectiveness'' scale-therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report. Int J Impot Res. 2004 ; 16 (3). 207-13.
17. Fitch K., Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica (CA): RAND; 2001.
18. Shekelle P. The appropriateness method. Med Decis Making. 2004 ; 24 (2). 228-31.
19. Tobacman JK, Scott IU, Cyphert ST, Zimmerman MB Comparison of appropriateness ratings for cataract surgery between convened and mail-only multidisciplinary panels. Med Decis Making. 2001 ; 21 (6). 490-7.
20. Kahan JP, Loo van het M. Defining appropriate health care. Eurohealth. 1999 ; 5 (3). 16-18.
21. Broder MS, Kanouse DE, Mittman BS, Bernstein SJ The appropriateness of recommendations for hysterectomy. Obstet Gynecol. 2000 ; 95 (2). 199-205.
22. Coulter I., Adams A., Shekelle P. Impact of varying panel membership on ratings of appropriateness in consensus panels: a comparison of a multi- and single disciplinary panel. Health Serv Res. 1995 ; 30 (4). 577-91.
23. Normand SL, Frank RG, McGuire TG Using elicitation techniques to estimate the value of ambulatory treatments for major depression. Med Decis Making. 2002 ; 22 (3). 245-61.
24. Quitkin FM, Stewart JW, McGrath PJ, et al. Are there differences between women's and men's antidepressant responses ? Am J Psychiatry. 2002 ; 159 (11). 1848-54.
25. Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J., Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants ? Am J Psychiatry. 2003 ; 160 (9). 1643-50.
26. Hess AL The relationship between gender, lifetime number of depressive episodes, treatment type, and treatment responses in chronic depression. DAI. 1999 ; 61 (01B). 148.
27. Zlotnick C., Elkin I., Shea MT Does the gender of a patient or the gender of a therapist affect the treatment of patients with major depression ? J Consult Clin Psychol. 1998 ; 66 (4). 655-9.
28. Hasin DS, Tsai WY, Endicott J., Mueller TI, Coryell W., Keller M. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord. 1996 ; 41 (1). 63-70.
29. Koike AK, Unutzer J., Wells KB Improving the care for depression in patients with comorbid medical illness. Am J Psychiatry. 2002 ; 159 (10). 1738-45.
30. Althuis MD, Sexton M., Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999 ; 36 (3). 257-64.
31. Ulrik CS, Lange P. Cigarette smoking and asthma. Monaldi Arch Chest Dis. 2001 ; 56 (4). 349-53.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Washington (DC): American Psychiatric Association ; 1994.
33. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Washington (DC): National Institutes of Health ; 2002.
34. Watkins KE, Burnam MA, Edelen MO, Escarce JJ, Huskamp HA, Goldman HH The Health Value and Cost of Care for Major Depression. Value in Health. In press.
35. McClellan M., Brook RH Appropriateness of care: a comparison of global and outcome methods to set standards. Med Care. 1992 ; 30 (7). 565-86.
36. Valenstein M., Vijan S., Zeber JE, Boehm K., Buttar A. The cost-utility of screening for depression in primary care. Ann Intern Med. 2001 ; 134 (5). 345-60.
37. Rutten-van Molken MPMH, Custers F., Van Doorslaer EKA, Jansen CCM, Heurman L. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J. 1995 ; 8 (6). 888-98.
38. Blumenschein K., Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol. 1998 ; 80 (2). 189-94.
39. Morton SC, Kominski GF, Kahan JP An examination of the Resource-Based Relative Value Scale cross-specialty linkage method. Med Care. 1994 ; 32 (1). 25-39.